Description

(2,3-Dihydro-Benzo[1,4]Dioxin-6-Yl)-(3-Methyl-Piperazin-1-Yl)-Methanone Hydrochloride is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents targeting central nervous system and other disorders. It is primarily sought by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in the production of active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly for neurological and psychiatric applications.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
• Active Pharmaceutical Ingredient (API) Development: Serves as a precursor in the multi-step synthesis of complex target molecules for clinical trials.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.
• Biochemical Research: Potential tool compound for investigating specific receptor interactions and biochemical pathways in vitro.
• Reference Standard: Can be utilized as a high-purity analytical standard for method development and quality control in API production.

Basic Information

Item	Detail
Product Name	(2,3-Dihydro-Benzo[1,4]Dioxin-6-Yl)-(3-Methyl-Piperazin-1-Yl)-Methanone Hydrochloride
CAS No.	1353958-43-6
Molecular Formula	C15H19ClN2O3
Molecular Weight	310.78 g/mol
Synonyms	6-[(3-Methyl-1-piperazinyl)carbonyl]-2,3-dihydro-1,4-benzodioxine hydrochloride; 1,4-Benzodioxin-6-carboxylic acid, 2,3-dihydro-, 1-(3-methyl-1-piperazinyl)-, monohydrochloride; (3-Methylpiperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methanone hydrochloride; (2,3-Dihydro-1,4-benzodioxin-6-yl)(3-methyl-1-piperazinyl)methanone hydrochloride
EINECS	Contact for details

Quality Control

Our (2,3-Dihydro-Benzo[1,4]Dioxin-6-Yl)-(3-Methyl-Piperazin-1-Yl)-Methanone Hydrochloride is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure compliance with exacting standards for pharmaceutical intermediates. A comprehensive Certificate of Analysis (COA) detailing purity, residual solvents, and related substances is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to prevent moisture absorption, which can affect stability and handling properties.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.